欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号LV/H/0219/001
药品名称Bendamustine Boston Biopharma 2.5 mg/ml powder for concentrate for solution for infusion
活性成分
    • bendamustine hydrochloride 2.5 mg/ml
剂型Powder for concentrate for solution for infusion
上市许可持有人UAB Boston Biopharma LT J. Savickio g. 4, Vilnius LT-01108, Lithuania
参考成员国 - 产品名称Latvia (LV)
互认成员国 - 产品名称
    • Lithuania (LT)
      -
    • Estonia (EE)
许可日期2022/06/01
最近更新日期2022/06/01
药物ATC编码
    • L01AA09 bendamustine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase